Sunny Pharmtech Balance Sheet Health
Financial Health criteria checks 6/6
Sunny Pharmtech has a total shareholder equity of NT$1.2B and total debt of NT$345.0M, which brings its debt-to-equity ratio to 28.8%. Its total assets and total liabilities are NT$1.7B and NT$512.4M respectively.
Key information
28.8%
Debt to equity ratio
NT$345.00m
Debt
Interest coverage ratio | n/a |
Cash | NT$270.66m |
Equity | NT$1.20b |
Total liabilities | NT$512.44m |
Total assets | NT$1.71b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 6676's short term assets (NT$460.5M) exceed its short term liabilities (NT$111.8M).
Long Term Liabilities: 6676's short term assets (NT$460.5M) exceed its long term liabilities (NT$400.6M).
Debt to Equity History and Analysis
Debt Level: 6676's net debt to equity ratio (6.2%) is considered satisfactory.
Reducing Debt: 6676's debt to equity ratio has reduced from 31.3% to 28.8% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 6676 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 6676 has sufficient cash runway for 1.5 years if free cash flow continues to grow at historical rates of 26.8% each year.